Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1992-01-21
1993-07-06
Stoll, Robert L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
5303913, 43524027, 935107, A61K 4902, A61K 39395
Patent
active
052251810
ABSTRACT:
There is provided a radiolabeled monoclonal antibody of the class IgG.sub.1 which reacts readily with both normal human and dog blood platelets while failing to react with thrombasthenic human platelets. This antibody has the property of completely blocking interaction of fibrinogen with platelets induced by ADP, and the ability to detect fresh thrombi in vivo.
REFERENCES:
patent: 4472509 (1984-09-01), Gansow et al.
patent: 4783330 (1988-11-01), Furie et al.
patent: 4820505 (1989-04-01), Ginsberg et al.
patent: 4990326 (1991-02-01), Noujaim et al.
Di Minno et al., Blood, vol. 61, No. 1, pp. 140-148 (1983).
Kornecki et al., Thrombosis Research, vol. 34, pp. 35-49, (1984).
Coller, J Clin Invest, vol. 72, pp. 325-338 (1983).
Coller et al., J. Lab and Clin. Med., vol. 107, No. 4, pp. 384-392 (1986).
"Monoclonal Ab Therapy for Heart Attacks", in Genetic Engineering News, vol. 9, No. 2, p. 1 (1989).
Yasuda et al., J. Clin Invest., vol. 81, pp. 1284-1291 (1988).
Mickelson et al., Circulation, vol. 81, No. 2, pp. 617-627 (1990).
Pidard et al., J. Biol. Chem., vol. 258, No. 20, pp. 12582-12586 (1983).
Oster et al., PNAS, USA, vol. 82, pp. 3465-3468 (1985).
Marchalonis et al., Antibody as a Tool, John Wiley and Sons, N.Y., pp. 224 and 456 (1982).
Bennett et al., PNAS, USA, vol. 80, pp. 2417-2421, (1983).
Vainchenker et al., Blood, vol. 59, No. 3, pp. 514-521 (1982).
Som et al., J. Nucl. Med., vol. 27, pp. 1315-1320, (1986).
Breddin, Sem. in Thrombosis and Hemostasis, vol. 15, No. 2 (1989).
Stuttle et al., Nucl. Med. Comm., vol. 9, pp. 647-655 (1988).
Stuttle et al., Nucl. Med. Comm., vol. 9, pp. 813-815 (1988).
Oster et al., AJR, vol. 152, pp. 253-260 (1989).
Oster et al., Radiology, vol. 171, No. 3, pp. 653-656 (1989).
Valone et al., Nucl. Med. Biol., vol. 15, No. 4, pp. 439-450 (1988).
Thurlow, P. J. et al., Br. J. Haematol., vol. 55, No. 1, pp. 122-134 (1983).
"A Murine Monoclonal Antibody that Completely Blocks the Binding of Fibrinogen to Platelets Produces a Thrombasthenic-like State in Normal Platelets and Binds to Glycoproteins 11b and/or 111a" by Barry S. Coller et al. J. Clin. Invest., 72(1), 325-38, 1983.
"Inhibition of Fibrogen Binding to Stimulated Human Platelets" Bennett, Joel S. et al Proc. Natl. Acad. Sci., 80(9) 1983, 2417-2421.
Genetic Engineering News, vol. 9, No. 2 "Monoclonal Ab Therapies for Heart Attacks" (Feb. 1989).
Yasuda et al., J. Clin. Invest., vol. 81, Apr. 1988, pp. 1284-1291.
Thiagarajan et al., J. Clin. Invest., vol. 75, Mar. 1985, pp. 896-901.
Thiagarajan et al., American Journal of Hematology, vol. 14, pp. 255-269 (1983).
Coller, J. Clin Invest. vol. 76, pp. 101-108 (1985).
Coller Barry S.
Meinken George E.
Srivastava Suresh C.
Covert John
Stoll Robert L.
The Research Foundation of State University of New York
LandOfFree
Radiolabeled antiplatelet monoclonal antibody for imaging in-viv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled antiplatelet monoclonal antibody for imaging in-viv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled antiplatelet monoclonal antibody for imaging in-viv will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1688085